Microbion has reported positive topline results from its Phase II study of pravibismane, a topical treatment for DFI.
At the 15mg dose, participants showed a sustained average weight loss of 22.9% during the three-year treatment. Credit: SB ...
The DACH region encompasses Germany, Austria, and Switzerland. Credit: Tom Korcak via Shutterstock. Amid tightening EU ...
They say lightning rarely strikes twice but Kezar Life Sciences has suffered its second clinical blow in as many months.
Despite this success, investors were unimpressed with the topline data, with Syndax’s stock dropping by 25.6%, from $21.78 ...
Medical advances and better knowledge of health have contributed to increased life expectancy and a growing elderly ...